SKYRIZI is a biologic that has been prescribed to more than 260,000 patients in the USA. * * Includes adults with: Plaque Psoriasis, Psoriatic Arthritis, Crohn’s disease, and Ulcerative Colitis. Data is …

Nov 11, 2025 · Skyrizi (risankizumab) is an injection used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. Includes indications, doses, interactions, side effects and more.

SKYRIZI® (risankizumab-rzaa) is contraindicated in patients with a history of serious hypersensitivity reaction to risankizumab-rzaa or any of the excipients. Serious hypersensitivity reactions, including …

Risankizumab, sold under the brand name Skyrizi (/ skaɪˈrɪzi / sky-RIZZ-ee), is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, and …

Aug 8, 2025 · Skyrizi (risankizumab-rzaa) is a brand-name drug used for plaque psoriasis, Crohn’s disease, and other conditions. Learn about side effects, uses, and more.

Skyrizi (risankizumab) treats symptoms of psoriasis, psoriatic arthritis and Crohn's disease by reducing inflammation in your body.

May 21, 2025 · Skyrizi (Risankizumab-rzaa Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …

Aug 21, 2024 · Find patient medical information for Skyrizi (risankizumab-rzaa) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

The SKYRIZI “Instructions for Use” contains more detailed instructions on the preparation and administration of SKYRIZI [see Instructions for Use]. Instruct the patient to read the Instructions for …

Dec 10, 2025 · Learn about dosage, side effects, and more of Skyrizi (risankizumab-rzaa), which is a prescription injection used to treat plaque psoriasis.